VJHemOnc is committed to improving our service to you

VJVirtual | Retrospective analysis of lenalidomide and thalidomide in myelofibrosis

VJHemOnc is committed to improving our service to you

Andrew Kuykendall

Andrew Kuykendall, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, explores results from a retrospective analysis of the clinical use and benefit of lenalidomide and thalidomide in myelofibrosis. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter